CVE-2025-30387

Summary

Improper limitation of a pathname to a restricted directory ('path traversal') in Azure allows an unauthorized attacker to elevate privileges over a network.

Affected Software

VendorProductVersion RangeStatus
MicrosoftAzure AI Document Intelligence Studio1.0.0 < 1.0.03019.1-official-7241c17aaffected

Weaknesses

  • CWE-22: CWE-22: Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')

ADP Enrichment

CISA ADP Vulnrichment

  • SSVC:
  • Exploitation: none
    • Automatable: yes
    • Technical Impact: total

References